Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis and Forecast
- 6.1. Drug Class Type
- 6.2. Route Of Administration
- 6.3. Duration Of Action
- 6.4. Distribution Channel
7. Global Market Analysis and Forecast, By Drug Class Type
- 7.1. Non-aqueous
- 7.2. Aqueous
8. Global Market Analysis and Forecast, By Route Of Administration
- 8.1. Gels
- 8.2. Ointments
- 8.3. Solutions
- 8.4. Adhesive Patch
9. Global Market Analysis and Forecast, By Duration Of Action
- 9.1. Short
- 9.2. Medium
- 9.3. Long
10. Global Market Analysis and Forecast, By Distribution Channel
- 10.1. Hospitals
- 10.2. Dental Clinics
- 10.3. Pharmacies and Drug Stores
- 10.4. E-commerce
11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. Asia Pacific
- 11.6. East Asia
- 11.7. MEA
12. North America Sales Analysis and Forecast, by Key Segments and Countries
13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
18. MEA Sales Analysis and Forecast, by Key Segments and Countries
19. Sales Forecast by Drug Class Type, Route Of Administration, Duration Of Action, and Distribution Channel for 30 Countries
20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
21. Company Profile
- 21.1. Astra Zeneca (UK)
- 21.2. Septodont (US)
- 21.3. Dentsply (US)
- 21.4. Sirona (US)
- 21.5. GlaxoSmithKline PLC (US)
- 21.6. Gilead Sciences Inc. (US)
- 21.7. Johnson & Johnson (US)
- 21.8. F. Hoffmann-La Roche Ltd. (Switzerland)
- 21.9. Baxter International Inc. (US)
- 21.10. Abbott Laboratories (US)
- 21.11. Hospira, Inc. (US)
- 21.12. Hikma Pharmaceuticals PLC (UK)
- 21.13. AbbVie Inc. (US)
- 21.14. Fresenius Se & Co. Kgaa (Germany)
- 21.15. Others
List of Tables
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Drug Class Type
Table 3: Global Market US$ Mn Forecast by Route Of Administration
Table 4: Global Market US$ Mn Forecast by Duration Of Action
Table 5: Global Market US$ Mn Forecast by Distribution Channel
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Drug Class Type
Table 8: North America Market US$ Mn Forecast by Route Of Administration
Table 9: North America Market US$ Mn Forecast by Duration Of Action
Table 10: North America Market US$ Mn Forecast by Distribution Channel
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Drug Class Type
Table 13: Latin America Market US$ Mn Forecast by Route Of Administration
Table 14: Latin America Market US$ Mn Forecast by Duration Of Action
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Drug Class Type
Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 19: Western Europe Market US$ Mn Forecast by Duration Of Action
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Drug Class Type
Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 24: Eastern Europe Market US$ Mn Forecast by Duration Of Action
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 26: Asia Pacific Market US$ Mn Forecast by Country
Table 27: Asia Pacific Market US$ Mn Forecast by Drug Class Type
Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration
Table 29: Asia Pacific Market US$ Mn Forecast by Duration Of Action
Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channel
Table 31: East Asia Market US$ Mn Forecast by Country
Table 32: East Asia Market US$ Mn Forecast by Drug Class Type
Table 33: East Asia Market US$ Mn Forecast by Route Of Administration
Table 34: East Asia Market US$ Mn Forecast by Duration Of Action
Table 35: East Asia Market US$ Mn Forecast by Distribution Channel
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Drug Class Type
Table 38: MEA Market US$ Mn Forecast by Route Of Administration
Table 39: MEA Market US$ Mn Forecast by Duration Of Action
Table 40: MEA Market US$ Mn Forecast by Distribution Channel
List of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF